Methacrylic Acid

Methacrylic Acid

SCHEMBL672402

C=C(C)C(=O)O.C=C(C)C(=O)O.CC(O)COC(C)COC(C)COC(C)COC(C)CO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.41
TSHR P16473 1/20 0.35
TGFBR1 P36897 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL8851520 1.00 TDP1 (0.41) TDP1TSHRTGFBR1
Methacrylic Acid SCHEMBL10531729 1.00 TDP1 (0.41) TDP1TSHRTGFBR1
Methacrylic Acid SCHEMBL10530377 1.00 TDP1 (0.41) TDP1TSHRTGFBR1
Methacrylic Acid SCHEMBL10531747 1.00 TDP1 (0.41) TDP1TSHRTGFBR1
Methacrylic Acid SCHEMBL5029016 1.00 TDP1 (0.41) TDP1TSHRTGFBR1
Methacrylic Acid SCHEMBL25256637 1.00 TDP1 (0.41) TDP1TSHRTGFBR1
Methacrylic Acid SCHEMBL142808 1.00 TDP1 (0.41) TDP1TSHRTGFBR1
Methacrylic Acid SCHEMBL11664734 1.00 TDP1 (0.41) TDP1TSHRTGFBR1
Methacrylic Acid SCHEMBL21670809 1.00 TDP1 (0.41) TDP1TSHRTGFBR1
Methacrylic Acid SCHEMBL628380 1.00 TDP1 (0.41) TDP1TSHRTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240197577-A1 SELF-ADHESIVE DENTAL MATERIAL KULZER GMBH (DE) 2024-06-20 US claimed
EP-4312945-A1 SELF-ADHESIVE DENTAL MATERIAL Kulzer GmbH (DE) 2024-02-07 EP claimed
WO-2022207877-A1 SELF-ADHESIVE DENTAL MATERIAL KULZER GMBH (DE) 2022-10-06 WO claimed
US-7078157-B2 Photosensitive composition and use thereof AZ ELECTRONIC MATERIALS USA CORP. (US) 2006-07-18 US claimed
EP-1602010-A2 PHOTOSENSITIVE COMPOSITION AND USE THEREOF AZ Electronic Materials USA Corp. (US) 2005-12-07 EP claimed
WO-2004077153-A2 PHOTOSENSITIVE COMPOSITION AND USE THEREOF AZ ELECTRONIC MATERIALS USA CORP. (US) 2004-09-10 WO claimed
US-20040175653-A1 Photosensitive composition and use thereof AZ ELECTRONIC MATERIALS USA CORP. 2004-09-09 US claimed
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2026-05-21 US disclosed
US-12609210-B2 Curable composition and cured body of same TOKUYAMA CORPORATION (JP) 2026-04-21 US disclosed
EP-3901185-B1 CURABLE COMPOSITION FOR OPTICAL MATERIALS, AND OPTICAL MATERIAL TOKUYAMA CORP (JP) 2026-03-25 EP disclosed
EP-4696722-A1 (METH)ACRYLATE, CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2026-02-18 EP disclosed
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article TOKUYAMA CORPORATION (JP) 2026-02-17 US disclosed
EP-4644435-A1 URETHANE (METH)ACRYLATE, CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENSES, AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2025-11-05 EP disclosed
US-7078157-B2 Photosensitive composition and use thereof AZ ELECTRONIC MATERIALS USA CORP. (US) 2006-07-18 US disclosed
EP-1602010-A2 PHOTOSENSITIVE COMPOSITION AND USE THEREOF AZ Electronic Materials USA Corp. (US) 2005-12-07 EP disclosed
WO-2004077153-A2 PHOTOSENSITIVE COMPOSITION AND USE THEREOF AZ ELECTRONIC MATERIALS USA CORP. (US) 2004-09-10 WO disclosed
US-20040175653-A1 Photosensitive composition and use thereof AZ ELECTRONIC MATERIALS USA CORP. 2004-09-09 US disclosed
US-6656633-B2 Binder for electrode for lithium ion secondary battery, and utilization thereof ZEON CORPORATION (JP) 2003-12-02 US disclosed
US-20020034686-A1 Electrochemical stability ZEON CORPORATION (JP) 2002-03-21 US disclosed
US-4194066-A POLYMERIZING POLYOXYALKYLENE GLYCOL (METH)ACRYLATES JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) 1980-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12609210-B2 Curable composition and cured body of same UACA, MMAB, SMCHD1 TDP1 2720/4885TSHR 960/4885TGFBR1 186/4885
US-20240197577-A1 SELF-ADHESIVE DENTAL MATERIAL CAD, MTHFD2, MAT2B TDP1 818/4885TSHR 1427/4885TGFBR1 2012/4885
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article C5, SCO2, ZYX TDP1 3584/4885TSHR 3533/4885TGFBR1 909/4885
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES CRYAA, FEM1B, MAPRE1 TDP1 4565/4885TSHR 4218/4885TGFBR1 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.